In a report released on January 9, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

Scorpion’s drug candidate inhibits a mutation that is a major driver of breast, gynaecological and head and neck cancers ...

Blackstone (BX) is mulling strategic options, including a sale, for mobile app marketing provider Liftoff that could value the company at over ...